Related by context. All words. (Click for frequent words.) 70 aptamer therapeutics 69 therapeutic monoclonal antibodies 68 commercialize microRNA therapeutics 68 adrenergic regulation 68 commercialize microRNA 67 Novosom 67 Adnectin 67 antisense drugs 66 siRNA therapeutics 66 RNA therapeutics 66 miRNA therapeutics 66 novel RNAi therapeutics 66 synthetic cannabinoid compounds 66 commercializing anti infective 66 immuno inflammatory diseases 65 novel peptides 65 Regulus Therapeutics LLC 65 immunotherapeutics 65 Adenosine Therapeutics 65 AKIP ™ 65 novel antiviral therapeutics 65 monoclonal antibody therapeutics 65 novel anti infective 64 antibody therapeutics 64 Nasdaq LXRX biopharmaceutical 64 romazarit 64 histone methyltransferases HMTs 64 acne impetigo 64 Nanobody 64 therapeutic antibodies 64 novel antibody therapeutics 64 IAP inhibitors 64 stem cell therapeutics 63 Nanobody ® 63 tiapamil 63 iPSC technology 63 human antibody therapeutics 63 novel therapeutic antibodies 63 epigenetic enzymes 63 commercialize Aganocides 63 RNAi therapeutics 63 anticancer therapeutics 63 Endotis 63 NTDDS 63 small molecule therapeutics 63 Kleanthis G. Xanthopoulos Ph.D. 63 dinosaurs Yokoyama 63 CCR9 antagonist 63 rxRNA 63 anticoagulant reversing agent 63 NuMimetic TM 63 Nanobodies 62 biotherapeutics 62 NovaBay Aganocide compounds 62 commercializing aptamer therapeutics 62 Dicer Substrate Technology 62 selective androgen receptor modulators 62 commercializing novel biotherapeutics 62 commercializing therapeutic 62 Vaccinex 62 siRNA compounds 62 peptide therapeutics 62 commercialize becocalcidiol patented 62 anticancer compounds 62 RNA interference RNAi therapeutics 62 cancer therapeutics 62 NYSE Amex AEN 62 oncology therapeutics 62 NNR Therapeutics 62 Provectus Pharmaceuticals specializes 62 identify protein biomarkers 61 oncolytic viruses 61 Stapled Peptide 61 engineered proteases 61 therapeutic monoclonal antibody 61 novel immunotherapies 61 ALN PCS 61 renin inhibition promising 61 Inc. AMEX YMI 61 Regulus Therapeutics 61 HuCAL antibody 61 Nanobodies R 61 novel therapeutics 61 immunologic diseases 61 antisense therapeutics 61 Avian Transgenic Technology 61 Inc. Nasdaq ALNY 61 SARMs 61 DPX Survivac 61 kidney urologic 61 Receptos 61 BCR ABL inhibitors 61 RNAi therapeutic 60 protein therapeutics 60 Brussels THR 60 Biolipox 60 HepDirect R 60 TRAIL receptor antibodies 60 RONDEL ™ 60 mGluR4 60 therapeutics 60 Zalicus 60 Quark Biotech 60 ArQule Kinase Inhibitor Platform 60 ALN TTR 60 dermatology therapies 60 peptide peptide mimetic 60 immunotherapeutic approaches 60 chemical entities NCEs 60 Nautilus Biotech 60 Morria Biopharmaceuticals Plc 60 Tranzyme 60 CobaCyte 60 beta secretase inhibitors 60 Archemix Corp. 60 renin inhibitors 60 RNA antagonists 60 pharmacological chaperone 60 Vegenics 60 cancer immunotherapies 60 EHT AGN 60 biologic therapeutics 60 Locked Nucleic Acid 60 nitric oxide donating 60 NOXXON 60 G Protein Coupled 60 Ore Pharmaceuticals 60 FOLOTYN ® 60 gastro intestinal inflammation 60 purinergic receptors P#X# 60 Sangamo ZFP technology 60 Agios Pharmaceuticals 60 humanized monoclonal antibodies 60 ophthalmology oncology 60 BioFocus DPI Galapagos 60 aTyr Pharma 60 DOS# 60 Nasdaq HALO biopharmaceutical 60 oligonucleotide therapeutics 60 small molecule thrombopoietin 60 NASDAQ SNTA biopharmaceutical 60 FoldRx Pharmaceuticals Inc. 60 molecular imaging radiopharmaceuticals 60 NASDAQ BTRX pharmaceutical 60 Galderma SA 60 regenerative therapeutics 60 Zacharon 60 commercialize apixaban 60 CAMBRIDGE Mass. Alnylam Pharmaceuticals 60 MEK inhibitors 60 SGLT inhibitors 60 EyeGate 60 leading oral taxane 60 optical biosensors 60 Nanobodies ® 60 Receptors GPCRs 60 proprietary dermal 60 preclinical compounds 60 Aganocide 59 theranostic 59 vaccines oncolytic virus 59 product platforms AZX# 59 Targeted Chemotherapy 59 companion diagnostics 59 antisense drug 59 FoldRx 59 Rosetta Genomics Nasdaq ROSG 59 antagomirs 59 using ImmunoGen TAP 59 Nasdaq ALNY 59 metaglidasen 59 prostone 59 ORTHOCON 59 small molecule agonists 59 MDRNA proprietary 59 Viprovex TM 59 ophthalmic diseases 59 OGeS 59 OTCBB NRGX biotechnology 59 histone deacetylase HDAC 59 VentiRx 59 cosmetic cosmeceutical products 59 inhibit metastasis 59 systemic RNA interference 59 LNPs 59 Combivir Kivexa 59 CureDM 59 DECIPHER R 59 candidate deforolimus 59 systemic RNAi 59 adrenal steroid hormones 59 XmAb ® 59 Epizyme 59 Heptares 59 taste modulators 59 Promedior 59 FORMA Therapeutics 59 XSSE OXGN 59 Lixivaptan 59 biased ligand 59 Anchor Therapeutics 59 CRMD pharmaceutical 59 humanized antibodies 59 UltiMAb 59 Viamet 59 KineMed 59 investigational pan BCR 59 Idun Pharmaceuticals 59 Homspera TM 59 Nasdaq MNKD focused 59 topical PTH #-# 59 Enzo Therapeutics 59 ArQule Kinase Inhibitor 59 Viprovex R 59 BHT DNA 59 PsychoGenics 59 siRNA delivery 59 Curaxin 59 Galenea 59 carbohydrate polymers 58 PDE4 inhibitor 58 Oracea TM 58 allosteric modulation 58 commercialize deforolimus 58 Mipomersen 58 oral taxane 58 targeted radiotherapeutic 58 molecular chaperone regulation 58 antisense inhibitors 58 Nanobody R 58 Quark Biotech Inc. 58 Kosan dependence 58 Cellzome 58 Isis antisense 58 pharmaceuticals nutritionals 58 Metallophile ™ Technology 58 IMiDs R 58 Anacor 58 BioMimetic seeks 58 GPCR targets 58 Alzheimer disease cognitive impairment 58 LNP formulations 58 acadesine 58 myelofibrosis polycythemia vera 58 Innovive Pharmaceuticals 58 delta gamma agonist 58 selective kinase inhibitors 58 EnVivo Pharmaceuticals 58 OTCBB NVLT biopharmaceutical 58 Selective Electrochemical Tumor Ablation 58 polymer conjugate technology 58 fibrosis oncology 58 lipid particles SNALP 58 NASDAQ ABII 58 small molecule activators 58 About Positron Positron 58 delights O'Dor 58 immunosuppressant therapies 58 Nasdaq PARD biopharmaceutical 58 OncoMed 58 ERYtech 58 pharmacogenetics 58 BioWa 58 small molecule PEGylation 58 ZFP technology 58 biosurgical 58 JAK2 kinase 58 RNAi therapeutic targeting 58 OTCQB CTIX 58 Guanilib 58 Ibis T# TM 58 IAP inhibitor 58 Roche SWX ROG 58 SR Pharma 58 PEGylation 58 Epothilones 58 proprietary PEGylation 58 target Galectin receptors 58 antiangiogenesis therapies 58 sirtuin therapeutics 58 neuronal nicotinic receptors NNRs 58 ophthalmic therapeutics 58 Alnylam #x# 58 Symadex 58 cardio metabolic diseases 58 antiviral therapeutics 58 COX FP Reuters NCOX.PA 58 selective immunoproteasome inhibitor 58 YM AIM YMBA 58 MKC# MKC# PP 58 MEDA AB publ 58 antibody fragment therapeutics 58 biomarker identification 58 Kwanika copper gold 58 neurodegenerative diseases oncology 58 www.ucb group.com 58 selective inhibitors 58 topical anti infective 58 Stapled Peptides 58 Panzem 58 rxRNA TM compounds 58 modulate sirtuins 58 siRNA therapeutic 58 Adnexus Therapeutics 58 candidates Azedra TM 58 novel peptide therapeutics 58 Nasdaq IDIX biopharmaceutical 58 PARP inhibitors 58 bioinformatic approaches 58 MTP inhibitor 58 staphylococcal vaccines 57 oral JAK#/JAK# inhibitor 57 ddRNAi 57 Theranostics 57 Excaliard 57 Epeius Biotechnologies Corporation 57 Aganocide compounds 57 LentiVector technology 57 Pentad TM 57 Dicerna 57 Panzem R 57 biotherapeutic 57 isoform selective 57 proven DuraSite ® 57 antibody humanization 57 Maxy G# 57 Cerimon Pharmaceuticals Inc. 57 theranostics 57 Cylene 57 novel peptide 57 Etubics 57 Nanobodies ® novel 57 Auspex Pharmaceuticals 57 Alnara Pharmaceuticals Inc. 57 Metaphore 57 bioinnovation 57 boron chemistry 57 Nasdaq RGDX 57 otelixizumab 57 dSLIM 57 Spiegelmers ® 57 Nasdaq RXII 57 Semafore 57 therapeutic modalities 57 proprietary NexACT ® 57 proprietary LNA 57 Pharma Merck Serono 57 A3 adenosine receptor 57 HDAC inhibition 57 targeted immunotherapies 57 class mGluR5 inhibitor 57 ChemoCentryx 57 CDP# 57 enhance ApoA 57 IMiDs 57 Ablaris Therapeutics 57 small molecule modulators 57 clinically validated targets 57 Albugon 57 personalized cellular immunotherapy 57 Amir Avniel 57 Onalta 57 Spiegelmers R 57 orthopedic regenerative medicine 57 Dyax phage display 57 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 57 intracellular signaling pathways 57 Ligand proprietary 57 AB OMXS BINV 57 Aviptadil 57 InterfeRx TM 57 P#X# 57 anticancer therapies 57 SCYNEXIS 57 molecular radiotherapeutics 57 oral prodrug 57 predictive biomarkers 57 ProLindac TM 57 Nasdaq OMER biopharmaceutical 57 rxRNA compounds 57 polymerase inhibitors 57 Archexin 57 ATL# [002] 57 Mycograb 57 Zemiva TM 57 Inc. Nasdaq INFI 57 ZaBeCor 57 drugable targets 57 Dapagliflozin 57 Myotech 57 PEGylation technology 57 epothilones 57 Isogenica 57 Personalized Immunotherapy 57 Onco TCS 57 NASDAQ CYTR biopharmaceutical 57 AKIP TM 57 Sphingomab 57 Transdel TM 57 novel immunomodulatory 57 Cobalamin TM mediated 57 JAK1 57 AngioGenex 57 GPR# agonist 57 4SC AG ISIN DE# 57 proprietary Dicer Substrate Technology 57 NeurAxon Inc. 57 diagnostic biomarkers 57 patented Bioral 57 Rotarix ® 57 Addrenex 57 autoimmune inflammatory 57 small molecule 57 nicotinic alpha 7 57 TSX YM AIM 57 Proteostasis 57 NASDAQ ALTH biopharmaceutical 57 OTCBB NPHC biotechnology 57 AcryMed technologies 57 investigational humanized monoclonal antibody 57 Epitomics 57 GPR# agonists 57 Aganocide TM 57 active personalized immunotherapies 57 Goldbrook quest 57 Intellikine 57 molecularly targeted 57 resolvins 57 prostones 57 novel orally administered 57 OTCBB URGP specialty 57 HuLuc# 57 Pancreate 57 biopharmaceuticals 57 DsiRNA 57 MPH AMEX 57 ImmuneRegen BioSciences Inc. 57 VitiGam 57 HuMax TAC 57 anti amnesic 57 anti infective treatments 57 Viamet Pharmaceuticals 57 Solazed TM 57 rusalatide acetate 57 Profectus BioSciences 57 Ferring Pharmaceuticals specializes 57 botanical therapeutics 57 liposomal delivery 57 oral ghrelin agonist 57 reverse vaccinology 57 THR beta agonist 57 Prednisporin 57 KuDOS 57 investigational therapies 57 Bioral 57 Acetylon 57 MP4 molecule 57 deliver innovative biomedicines 57 validating biomarkers 57 ALN TTR# 57 TSX VIR 57 small molecule inhibitors 57 endosomal release 56 vitreoretinal disorders 56 inflammatory disorders 56 cellular reprogramming 56 anticancer agents 56 rheumatoid arthritis thrombocytopenia 56 Nasdaq CGEN 56 rxRNA ™ compounds 56 product platforms GVAX 56 JAK inhibitor 56 molecular biomarkers 56 MolecularBreeding 56 Syncria 56 StromaCel Inc. 56 antiviral compounds 56 SMARTICLES ® 56 sulfonylhydrazine class 56 OSI Prosidion 56 JAK inhibitors 56 lipid mediators 56 ActivX 56 proprietary Biochronomer 56 infectious diseases autoimmune diseases 56 Piramed 56 protein tyrosine phosphatases 56 Sirona Biochem 56 aptamers 56 Biomoda www.biomoda.com 56 MEK inhibitor 56 XmAb ™ 56 HIF biology 56 Wadih Arap 56 New Chemical Entities 56 molecular imaging pharmaceuticals 56 Ambrx 56 oral gallium 56 Board LWLG technology 56 staphylococcal vaccine 56 CYT# potent vascular disrupting 56 Dr. Marlies Sproll 56 biologic therapies 56 sd rxRNA 56 RECOTHROM ® 56 AtuRNAi 56 anti angiogenic drugs 56 GENFIT 56 Anaphore 56 recombinant biopharmaceutical 56 Fibroblast Growth Factor Receptor 56 Roche SWX ROG.VX 56 EndoTAG TM 56 CB2 receptor selective 56 advancing microRNA therapeutics 56 tranilast 56 Fibrin MB 56 oral proteasome inhibitor 56 PharmFilm ® 56 developing TB4 56 Orapred ODT 56 Transdel TM platform 56 clinically differentiated 56 PORxin TM platforms 56 Angiocept 56 Galectin therapeutics 56 CB2 selective 56 multi kinase inhibitor 56 investigational monoclonal antibody 56 ospemifene 56 Alnylam RNAi 56 biochemical profiling 56 Idera Pharmaceuticals 56 PolyTherics 56 OXIGON TM 56 Ustekinumab 56 Hsp# inhibition 56 neuro inflammatory 56 Vitamin D analogue 56 Nektar pulmonary 56 molecular imaging radiopharmaceutical 56 MediGene focuses 56 AAG geldanamycin analog 56 Liprotamase 56 cMET 56 EpiTherapeutics 56 DNAi 56 rheumatoid arthritis multiple sclerosis 56 lead molecular radiotherapeutic 56 Gemin X 56 Applied NeuroSolutions 56 Currently RegeneRx 56 oncolytic 56 NexGenix 56 pralatrexate injection folate analogue 56 Nexavar ® 56 XmAb 56 autologous cell 56 antibody humanization patents 56 Crop BioScience 56 Restoraderm 56 tkRNAi technology 56 Intradigm Corporation 56 CD# CEA 56 proprietary BiTE antibody 56 Tesetaxel 56 oral antiviral 56 Monoclonal antibody 56 Affibody ® molecules 56 adenosine A2A 56 Lipocine 56 Avila Therapeutics 56 Exelixis compounds 56 OncoMed Pharmaceuticals 56 Euroscreen 56 constipation OIC 56 PEGylated 56 Fleximer R 56 oral transdermal 56 PNP inhibitor 56 ANAVEX 56 kinase inhibitors 56 blood serum biomarkers 56 Selzentry Celsentri 56 Relypsa 56 investigational oral anticoagulant 56 multivalency toward drug 56 manufacturing interventional vascular 56 HCV protease inhibitors 56 Nasdaq CNCT specialty 56 glucagon receptor 56 Alnylam Pharmaceuticals 56 dermatological diseases 56 Nasdaq MBRX announced 56 diabetes irritable bowel 56 metalloenzymes 56 ABL inhibitor 56 Locked Nucleic Acid LNA 56 FGFR 56 Smac mimetics 56 Scaffold Based 56 Regado 56 psoriasis rheumatoid arthritis 56 AEG# 56 EyeGate Pharma 56 lixivaptan 56 covalent drugs 56 influenza hypercholesterolemia 56 miRagen 56 Aganocide ® 56 Neurogen Corporation 56 allosteric modulator 56 including Cobalamin TM 56 selective inhibition 56 Inc. NASDAQ CRIS 56 BioSilicon TM 56 Nasdaq IMGN biotechnology 56 SGLT Inhibitors 56 OTCBB PYTO FWB ET6 56 tesetaxel 56 catalytic antioxidant compounds 56 arterial puncture closure 56 polyneuropathy HIV DSP 56 Pervasis Therapeutics Inc. 56 Cascade LifeSciences 56 ISIN FR# biopharmaceutical 56 Aquinox 56 immunological diseases 56 Amira Pharmaceuticals 56 Aganocide R 56 FluoroPharma 56 Afferent Pharmaceuticals 56 candidate custirsen 56 specific lectin receptors 56 synthetic genomics 56 AVEO integrates proprietary 56 anti infective medicines 56 Symphogen 56 Transdel ™ 56 sodium thiosulfate STS 56 anionic backbone 56 dAbs 56 aTyr 56 glucokinase activator 56 PROfusion 56 liposome formulations 56 Epiphany Biosciences 56 DiLA2 56 Synavive ™ 56 proprietary bioresorbable polymer 56 DXL# 56 Miraxion Amarin lead 56 ProtoKinetix 56 antibiotic anti infective 56 CyDex Pharmaceuticals Inc. 56 CysDisplay R 56 PDE# inhibitors 56 cancer therapeutics Adherex 56 ocular diseases 56 Surfaxin LS 56 Apexigen 56 RNAi 56 Merck Serono division 56 ATL# [001] 56 CYT# novel 56 PI3K/Akt pathway inhibitor 56 Alligator Bioscience AB 56 Cobalamin ™ 56 JAK2 inhibitor 56 proprietary phage display 56 inflammatory autoimmune diseases 56 GlycArt 56 epigenetic therapeutics 56 monoclonal antibody MAb 56 Tranzyme Pharma 56 cardiovascular metabolic 56 Genedata Expressionist ® 56 Fleximer 56 BioSeek 56 NeuroSolutions 56 Alnylam 56 SNALP 56 protein tyrosine phosphatase 1B 56 OTCBB PWRM.OB 55 TLR9 agonists 55 Plasma Converter TM 55 anti infectives 55 proprietary MSCRAMM ® 55 leukotriene pathway 55 Regado Biosciences 55 myeloproliferative disorders 55 Velcera 55 CalciMedica 55 commercialize conjugates consisting 55 diarrhea predominant irritable 55 J. Mazzo Ph.D. 55 resorbable biomaterials 55 vascular disrupting agents 55 tests miRview TM 55 protein kinase inhibitors 55 Captisol ® 55 Peyronie disease Frozen Shoulder 55 Betrixaban 55 Advinus 55 HCV NS3 protease 55 Forma Therapeutics 55 cyclophilin inhibitors 55 IMiDs ® 55 ProNAi 55 oncolytic vaccine 55 Chemokine Therapeutics 55 Spiegelmer 55 MicroDose 55 Taligen 55 Incretin mimetics 55 OTCBB CTIX 55 DGAT1 inhibitors 55 Unit Dose Budesonide 55 Disease IBD 55 Atiprimod 55 NexACT R 55 monoclonal antibodies 55 Myrexis Inc. 55 OTC BB PVCT http:/www.pvct.com 55 OPi 55 epithermal gold mineralized 55 ImmunoCellular 55 Neogenix 55 Tobira Therapeutics 55 Curaxins 55 epothilone 55 ALN RSV program 55 Affilin ® 55 Regulus Therapeutics joint venture 55 NasdaqGM SPPI 55 ALTROPANE R 55 Safinamide 55 Ophthotech 55 AzaSite Xtra 55 fusion enhancers 55 SMaRT ™ 55 Scancell 55 Virulizin ® 55 autologous cellular therapy 55 GSK Rare Diseases 55 histone deacetylase HDAC inhibitors 55 XL# XL# 55 Apokyn R 55 ophthalmology dermatology cardiovascular disease 55 Affimed 55 ViroChem 55 Syndax Pharmaceuticals Inc. 55 Inc. NASDAQ AEZS 55 ATL/TV# 55 Cetrorelix 55 Inc. NASDAQ IDIX 55 sodium glucose transporter 55 Photodynamic Therapy PDT 55 San Diego Amira Pharmaceuticals 55 HIV integrase inhibitors 55 AMEX REX 55 POTELLIGENT R 55 AutoloGel tm System 55 Vernalis plc 55 L BLP# 55 MorphoSys Galapagos 55 protein kinase inhibitor 55 prodrugs 55 small molecule defensin 55 M2 subunit 55 Bioaccelerate compounds under 55 synthetic retinoid 55 LEX System 55 candidate CRLX# 55 Thiakis 55 AngioChem 55 Darapladib 55 Xanthus Pharmaceuticals Inc. 55 ARIKACE ™ 55 superparamagnetic iron oxide nanoparticles 55 oncology metabolic disorders 55 Duncan Higgons 55 HSP# inhibitors 55 GI motility disorders 55 Inc. Nasdaq NLTX 55 Alfacell proprietary ribonuclease 55 Adamis Viral Therapies 55 vaccine GRNVAC1 55 therapeutic modality 55 investigational compounds 55 OTCBB INSV 55 LentiVector 55 undruggable targets 55 RenaZorb TM 55 Virosome Biologicals 55 RNAi Therapeutics 55 deforolimus 55 ELADUR ™ 55 non personalized allogeneic 55 NNRs 55 RNAi gene silencing 55 Kiadis 55 synergistic combinations 55 Argenta Discovery 55 NASDAQ LGND 55 biased ligands 55 NPC 1C 55 immunotherapeutic 55 Immunotope 55 SinuNase ™ 55 Catabasis 55 HCV protease inhibitor 55 Sirius Genomics 55 PERCIVIA 55 biotherapeutic drugs 55 Pepducin 55 patented NanoStat ™ 55 PRNewswire FirstCall Neurogen 55 EGFR HER 55 Salmedix 55 anti CD3 monoclonal 55 TOCOSOL Camptothecin 55 liposomal 55 Nasdaq MITI biopharmaceutical 55 superior biotherapeutics 55 NASDAQ AVEO biopharmaceutical 55 cancer immunotherapy 55 TLR8 55 MCSP respectively 55 HCV polymerase inhibitors 55 Angioblast 55 transcatheter valve technologies 55 HELSINN 55 Ibis Biosciences 55 stable nucleic acid 55 Response Genetics Inc. 55 autoimmune indications 55 sodium glucose cotransporter 55 Ipsen Euronext IPN 55 Prodarsan R 55 vivo fluorescence imaging 55 subsidiaries visit http:/www.apricusbio.com 55 CB1 antagonists 55 Genasense evaluating 55 translational medicine 55 innovative signaling pathway 55 acetonide FA 55 Sentinel Principle 55 Ostabolin C TM 55 CTLA4 Ig product 55 aesthetic dermatology 55 INS# [001] 55 leverages Cytokinetics 55 imaging radiopharmaceuticals 55 Archemix 55 ADMETRx 55 Nasdaq VNDA 55 AIM SLN 55 SNT MC# 55 including eniluracil ADH 55 molecular biology genomics 55 proliferative diseases 55 ADME properties 55 microRNA antagonists 55 bio therapeutics 55 Celator 55 neovascular diseases 55 Affibody 55 TLR Therapeutics 55 HGS ETR1 mapatumumab 55 biologically validated targets 55 XmAb# 55 UltiMAb ® 55 dihydrochloride Tablets 55 renin inhibitor 55 ImmunoGen TAP technology 55 biomarker discovery 55 AN# novel 55 Biotica 55 mucosal vaccines 55 developing Bicifadine serotonin 55 Biopharma OTCBB VODG 55 Sphingomab TM 55 miR #b [002] 55 infectious autoimmune 55 Daclizumab 55 lipid nanoparticle 55 GSK '# 55 P#X# antagonist 55 LensAR 55 CCX# 55 tubulin inhibitor 55 RECOTHROM R 55 platform HDL Mimetic 55 TSX VENTURE DMA 55 CCR3 55 DGAT 55 humanized monoclonal antibody 55 telomerase therapeutic 55 InNexus 55 NS5b 55 Myocet 55 teplizumab 55 Litx 55 Paramount BioSciences 55 enhanced skin permeation 55 outlicensing 55 Ridaforolimus 55 MyVax ® 55 Alnylam Biotherapeutics 55 #ME# 55 HuCNS SC ® 55 5 HT6 55 AlphaRx 55 URG# 55 venomics 55 Tarmogen 55 Hematide ™ 55 mGluR4 PAM 55 engineered RAP peptides 55 Inc. OTCBB IRBS 55 Inc. OTCBB LPTN 55 specialty pharma 55 ARIAD vision 55 ZFP TF 55 Chemizon 55 Chrysalin 55 recombinant antibodies 55 Alnara Pharmaceuticals 55 JAK2 Inhibitor 55 Anticalins R 55 Belimumab 55 Zolinza 55 Chemetics R 55 druggable targets 55 neurology immunology 55 motexafin gadolinium Injection 55 Adrenomyeloneuropathy AMN HIV 55 antisense 55 proteasome inhibitors 55 NASDAQ DYAX 55 PDE7 55 therapeutic antibody 55 TASE EVGN.TA 55 Fovea Pharmaceuticals subsidiary 55 ESBA# 55 label Lipofen R 55 Bellicum Pharmaceuticals Inc. 55 chimeric antibodies 55 ZFP Therapeutics 55 Ceflatonin R 54 therapeutic radiopharmaceuticals 54 Rutherford Procedure 54 DXL TM antibodies 54 cardiometabolic disorders 54 sirtuin modulators 54 antiviral therapies 54 candidate Zenvia 54 biodefense pathogens 54 trademarks Vitrasert R 54 MetaBase TM represents 54 Dynepo TM 54 MAXY VII 54 Opexa Therapeutics 54 immuno oncology 54 dipeptidyl peptidase IV 54 commercialize elagolix 54 oral salmon calcitonin 54 mTOR kinase 54 Hemopurifier ® captures 54 oncolytic virus therapies 54 exon skipping 54 Intermezzo ® zolpidem tartrate 54 Ikaria Holdings Inc. 54 Proteon Therapeutics Inc. 54 non nucleoside HCV 54 MCU cardiovascular 54 PharmaFrontiers 54 orphan GPCRs 54 AcryMed Incorporated 54 equine osteoarthritis 54 PDGF receptor 54 CBLC# 54 gastrointestinal mucositis 54 Ph.D. Targacept 54 BRAF kinase 54 Pharmacopeia Nasdaq PCOP 54 OMP #M# 54 Inc. OTCBB BMSN 54 novel VDA molecule 54 autoimmune diseases 54 Unigene Biotechnologies 54 coupled receptors GPCRs 54 bioactive lipids 54 Inc. dba Vitro 54 cognitive impairment associated 54 chemically modified siRNA 54 TPI ASM8 54 HGS#